Comparison of outcomes of EUS-guided ablation and surveillance only for pancreatic cystic lesions: a propensity score matching study (with videos).

EUS-REL was associated with a significantly lower 10-year cumulative incidence rate of BD-IPMN progression and a lower tendency of SR, while its 10-year OS and DSS were similar to those of SO for PCLs. EUS-REL may be a viable alternative to SO for managing patients with enlarging suspected BD-IPMNs or those with PCLs >3cm who are suboptimal candidates for surgery.